menu
    • menu

    Company profile for UBI Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    UBI Pharma was established on July 31, 2014 as a spin-off company from United Biomedical, Inc., Asia. UBI Pharma specializes in developing and manufacturing fusion protein drugs and formulations of small molecule pharmaceuticals. UBI Pharma is dedicated to developing biobetters and specialty injectables on exclusively owned long-acting protein drug platforms, such as fusion proteoglycan, fusion single Fc chain, and new form...
    UBI Pharma was established on July 31, 2014 as a spin-off company from United Biomedical, Inc., Asia. UBI Pharma specializes in developing and manufacturing fusion protein drugs and formulations of small molecule pharmaceuticals. UBI Pharma is dedicated to developing biobetters and specialty injectables on exclusively owned long-acting protein drug platforms, such as fusion proteoglycan, fusion single Fc chain, and new formulations. UBI Pharma has the US FDA registered and inspected facility with approved products in Asia outside of Japan.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    UBI PharmaTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    No 45, Guangfu N. Rd, Hukou Township, Hsinchu County, 30351
    Telephone
    Telephone
    03-5979288
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ubi-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    UBI`s Generics Olanzapine Receives Approval in US
    UBI`s Generics Olanzapine Receives Approval in US

    11 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211072

    FDA
    11 Jun 2025
    Share Share
    UBI's Generic Voriconazole Fumarate Receives Approval in the U.S.
    UBI's Generic Voriconazole Fumarate Receives Approval in the U.S.

    09 Mar 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211264

    FDA
    09 Mar 2023
    Share Share
    UBI's Generic Caspofungin Acetate Receives Approval in the US
    UBI's Generic Caspofungin Acetate Receives Approval in the US

    01 Oct 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211263

    FDA
    01 Oct 2021
    Share Share
    Taiwan rejects COVID vaccine candidate, president to get domestic shot
    Taiwan rejects COVID vaccine candidate, president to get domestic shot

    16 Aug 2021

    // REUTERS

    https://www.reuters.com/article/us-health-coronavirus-taiwan-vaccine/taiwan-rejects-covid-vaccine-candidate-president-to-get-domestic-shot-idUSKBN2FH0MC

    REUTERS
    16 Aug 2021
    Share Share
    UBI's Generic Desmopressin Acetate Receives Approval In US
    UBI's Generic Desmopressin Acetate Receives Approval In US

    21 Sep 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210223

    FDA
    21 Sep 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search